Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TDGF1 antibody (AA 1-50)

TDGF1 Reactivity: Human, Mouse WB, IF, FACS, ICC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN540265
  • Target See all TDGF1 Antibodies
    TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
    Binding Specificity
    • 15
    • 6
    • 6
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-50
    Reactivity
    • 60
    • 18
    • 8
    Human, Mouse
    Host
    • 42
    • 19
    • 2
    • 1
    Rabbit
    Clonality
    • 43
    • 20
    Polyclonal
    Conjugate
    • 22
    • 6
    • 6
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This TDGF1 antibody is un-conjugated
    Application
    • 34
    • 32
    • 24
    • 13
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Purpose
    Rabbit polyclonal antibody raised against synthetic peptide of Tdgf1.
    Specificity
    This antibody is specific to cripto.
    Cross-Reactivity
    Human, Mouse
    Characteristics
    Antibody Reactive Against Synthetic Peptide.
    Immunogen
    A synthetic peptide corresponding to amino acids 1-50 of mouse Tdgf1.
    Top Product
    Discover our top product TDGF1 Primary Antibody
  • Application Notes
    Flow Cytometry (1:100)
    Immunocytochemistry (1:50-1:200)
    Immunofluorescence (1:50-1:200)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In Tris-glycine, 150 mM NaCl
    Storage
    4 °C
    Storage Comment
    Store at 4°C. Do not freeze.
  • Xing, Hu, Pietersz, Hosick, McKenzie: "Cripto: a novel target for antibody-based cancer immunotherapy." in: Cancer research, Vol. 64, Issue 11, pp. 4018-23, (2004) (PubMed).

    Adamson, Minchiotti, Salomon: "Cripto: a tumor growth factor and more." in: Journal of cellular physiology, Vol. 190, Issue 3, pp. 267-78, (2002) (PubMed).

    Schiffer, Foley, Kaffashan, Hronowski, Zichittella, Yeo, Miatkowski, Adkins, Damon, Whitman, Salomon, Sanicola, Williams: "Fucosylation of Cripto is required for its ability to facilitate nodal signaling." in: The Journal of biological chemistry, Vol. 276, Issue 41, pp. 37769-78, (2001) (PubMed).

  • Target
    TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
    Alternative Name
    TDGF1 / CRIPTO (TDGF1 Products)
    Synonyms
    CR antibody, CRGF antibody, CRIPTO antibody, CR1 antibody, cripto antibody, cb85 antibody, tdgf1 antibody, wu:fe01d04 antibody, zgc:109829 antibody, Cripto-1 antibody, cr1 antibody, cr1a antibody, frl-1 antibody, frl1 antibody, xcr1 antibody, TDGF1 antibody, tdgf3 antibody, cripto-3 antibody, teratocarcinoma-derived growth factor 1 antibody, teratocarcinoma-derived growth factor 1, member 3 L homeolog antibody, teratocarcinoma-derived growth factor 1, member 1 antibody, TDGF1 antibody, Tdgf1 antibody, tdgf1 antibody, tdgf1.3.L antibody, tdgf1.1 antibody
    Gene ID
    21667
    Pathways
    EGFR Signaling Pathway
You are here:
Support